A Multi-Reader Multi-Case Pivotal Trial

Status:	Completed
Conditions:	Breast Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	4/21/2016
Start Date:	December 2015
End Date:	January 2016

A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm FFDM Plus DBT Versus FFDM Alone in the Detection of Breast Cancer

The purpose of this pivotal reader study is to assess the comparative accuracy of Fujifilm
FFDM plus DBT versus FFDM alone in the detection of breast cancer.

The safety and effectiveness of FFDM + DBT are both linked to the ability of radiologists
interpreting FFDM + DBT images to accurately diagnose breast cancer. Each study endpoint
therefore addresses both safety and effectiveness.

Inclusion Criteria:

- Eligible subjects under protocol FMSU2013-004A, defined as female subjects with known
true clinical status and with complete FFDM and DBT examinations, in which there is
sufficient anatomical coverage, sufficient contrast, and no significant motion or
other artifacts, as determined by the image-acquisition sites.

- Meet none of the exclusion criteria under protocol FMSU2013-004A.

Exclusion Criteria:

- Subjects who are in violation of protocol FMSU2013-004A.

- Subjects who meet exclusion criteria under protocol FMSU2013-004A.

- Subjects with unknown clinical status.

- Any subject whose positive mammogram was not read during the truthing process (see
section 8) will not be considered for the pivotal MRMC reader study.

We found this trial at

sites

Elizabeth Wende Breast Care, LLC (EWBC)

Rochester, New York 14620

from

Rochester, NY